Metallothioneins in human kidneys and associated tumors

Nephron

Volumn 83, Issue 4, 1999, Pages 331-340

  Hellemans, Godelieve ^b   Soumillion, Ann ^b   Proost, Paul ^b   Van Damme, Jo ^b   Van Poppel, Hein ^b   Baert, Luc ^b   De Ley, Marc ^a  

^a Department of Chemistry   (Belgium)

^b NONE

Author keywords

Adenocarcinoma; Kidney; Metallothionein; Oncofetal marker; Transitional cell carcinoma

Indexed keywords

CADMIUM; COPPER; METALLOTHIONEIN; ZINC;

ADENOCARCINOMA; ADULT; AGED; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0005580681     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045425     Document Type: Article

References (29)

1. Kägi JHR, Kojima Y: Chemistry and biochemistry of metallothionein. Experientia 1987;52: 25-62.
2. Hunziker PE, Kägi JHR: Isolation and characterization of six human hepatic isometallothioneins. Biochem J 1985;231:375-382.
3. Palmiter RD, Findley SD, Whitmore TE, Durnam DM: MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA 1992;89:6333-6337.
4. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD: Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994; 33:7250-7259.
5. Andrews GK, Adamson ED, Gedamu L: The ontogeny of expression of murine metallothionein: Comparison with the α-fetoprotein gene. Dev Biol 1984;103:294-303.
6. Clough SR, Mitra RS, Kulkarni AP: Qualitative and quantitative aspects of human fetal liver metallothioneins. Biol Neonate 1986;49: 241-254.
7. Soumillion A, Van Damme J, De Ley M: Cloning and specific polymerised-chain-reaction amplification of a third charge-separable human metallothionein isoform. Eur J Biochem 1992;209:999-1004.
8. Pauwels M, Van Weyenbergh J, Soumillion A, Proost P, De Ley M: Induction by zinc of specific metallothionein isoforms in human monocytes. Eur J Biochem 1994;220:105-110.
9. Cherian MG: The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ Health Perspect 1994;102:131-135.
10. Zhang XH, Takenaka I: Incidence of apoptosis and metallothionein expression in renal cell carcinoma. Br J Urol 1998;81:9-13.
11. Pattanaik A, Shaw CF III, Petering DH, Garvey J, Kraker AJ: Basal metallothionein in tumors: Widespread presence of apoprotein. J Inorg Biochem 1994;54:91-105.
12. Sendelbach LE, Klaassen CD: Kidney synthesizes less metallothionein than liver in response to cadmium chloride and cadmium metallothionein. Toxicol Appl Pharmacol 1988;92:95-102.
13. Shaikh ZA, Kido T, Kito H, Honda R, Nogawa K: Prevalence of metallothionein among the population living in the Kakehashi River basin in Japan - an epidemiological study. Toxicology 1990;64:59-69.
14. Dorian C, Gattone VH II, Klaassen CD: Accumulation and degradation of the protein moiety of cadmium metallothionein (CdMT) in the mouse kidney. Toxicol Appl Pharmacol 1992; 117:242-248.
15. Dorian C, Gattone VH II, Klaassen CD: Discrepancy between the nephrotoxic potencies of cadmium metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules. Toxicol Appl Pharmacol 1995;130:161-168.
16. Savolainen H: Cadmium-associated renal disease. Renal Fail 1995;17:483-487.
17. Mididoddi S, McGuirt JP, Sens MA, Todd JH, Sens DA: Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett 1996;85:17-27.
18. Hoey JG, Garrett SH, Sens MA, Todd JH, Sens DA: Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures and renal cell carcinoma. Toxicol Lett 1997;92:149-160.
19. Bradford MM: A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
20. Eaton DL, Toal B: Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxicol Appl Pharmacol 1982;66:134-142.
21. Friedman M, Krull LH, Cavins JM: Chromatographic determination of cystine and cysteine residues in proteins as S-β-(4-pyridylethyl)cysteine. J Biol Chem 1970;245:3868-3871.
22. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Aviv H, Leder P: Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid cellulose. Proc Natl Acad Sci USA 1972;69:1408-1412.
24. Hunziker PE: Purification of human isometallothioneins. Methods Enzymol 1991;205:244-247.
25. Onosaka S, Min K, Fukuhara C, Tanaka K, Tashiro S, Shimizu I, Futura M, Yasutomi T, Kobashi K, Yamamoto K: Concentrations of metallothionein and metals in malignant and non-malignant tissues in human liver. Toxicology 1986;38:261-268.
26. Chung J, Nartey NO, Cherian MG: Metallothionein levels in liver and kidney of Canadians - a potential indicator of environmental exposure to cadmium. Arch Environ Health 1986;41:319-323.
27. Syversen TLM, Stray TK, Syversen GB, Ofstad J: Cadmium and zinc in human liver and kidney. Scand J Clin Lab Invest 1976;36:251-256.
28. Saika T, Tsushima T, Nasu Y, Akebi N, Noda M, Kobashi K, Matsumura Y, Ohmori H: Histopathological study of metallothionein in bladder cancer and renal cell carcinoma. Nippon Hinyokika Gakkai Zasshi 1992;83:636-642.
29. Mulder TPJ, Janssens AR, Verspaget HW, van Hattum J, Lamers CBHW: Metallothionein concentration in the liver of patients with Wilson's disease, primary biliary cirrhosis, and liver matastasis of colorectal cancer. J Hepatol 1992;16:346-350.